Webinar: Targeting oxygen sensing in cancer
Posted: 8 January 2021 | Bio-Techne | No comments yet
This webinar from Bio-Techne discusses canonical and alternative oxygen sensing mechanisms implicated in cancer therapy resistance and recurrence.
Hypoxia is an emerging hallmark of solid tumors. It is typically transduced to the nucleus of cancer cells by HIF-dependent transcription; however, recent evidence implies that other HIF-independent pathways are activated. This webinar from Bio-Techne discusses oxygen sensing mechanisms implicated in cancer therapy resistance and recurrence, and highlights evidence suggesting conventional chemotherapy might act as an oxygen-independent HIF inducer, thus promoting therapy failure and metastasis.
Related topics
Antibodies, Disease research, Drug Targets, Metabolomics, Oncology
Related organisations
Bio-Techne